Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDB1 | Q16531 | 5/20 | 0.45 |
| ▸ | CRBN | Q96SW2 | 5/20 | 0.45 |
| ▸ | KDR | P35968 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31355824 | 1.00 | DDB1 (0.45) | DDB1CRBNKDRMEN1KMT2A | |
| SCHEMBL31356001 | 0.90 | CRBN (0.43) | DDB1CRBNSMN1; SMN2MAPTMAPK1 | |
| SCHEMBL31485122 | 0.88 | CASP3 (0.47) | DDB1CRBNMEN1KMT2AMAPT | |
| SCHEMBL31355828 | 0.88 | DDB1 (0.43) | DDB1CRBNACHE | |
| SCHEMBL31355846 | 0.84 | DDB1 (0.48) | DDB1CRBNMEN1KMT2A | |
| SCHEMBL31355968 | 0.84 | DDB1 (0.48) | DDB1CRBNMEN1KMT2A | |
| SCHEMBL31355960 | 0.84 | DDB1 (0.48) | DDB1CRBNMEN1KMT2A | |
| SCHEMBL31485048 | 0.81 | DDB1 (0.43) | DDB1CRBN | |
| SCHEMBL31356020 | 0.80 | CRBN (0.43) | DDB1CRBNKDRSMN1; SMN2 | |
| SCHEMBL31355870 | 0.80 | DDB1 (0.46) | DDB1CRBNSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025026422-A1 | ARYL OR HETEROARYL SUBSTITUTED GLUTARIMIDE DERIVATIVE AND USE THEREOF | 标新生物医药科技(上海)有限公司 | 2025-02-06 | — | — | WO | claimed |